Laden...
You are subscribed to HIVinfo Weekly Twitter Digest. This information has recently been updated, and is now available.
| HIVinfo.NIH.gov HIVinfo_NIH | 13 Jan | |
| RT @US_FDA: Today we approved the first injectable treatment for use in at-risk adults and adolescents weighing at least 35 kilograms (77 p | ||
| Details | Retweet | ||
| HIVinfo.NIH.gov HIVinfo_NIH | 13 Jan | |
| Harm reduction is love @hanselt Learn more about harm reduction efforts at the @IDEAexchangeMIA where a @NIDAnews https://t.co/fSa1ZGfqTj | ||
| Details | Retweet | ||
| HIVinfo.NIH.gov HIVinfo_NIH | 10 Jan | |
| Recent Updates to Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce https://t.co/prR4VHHZg0 | ||
| Details | Retweet | ||
| HIVinfo.NIH.gov HIVinfo_NIH | 10 Jan | |
| Read the OAR Directors latest blog, NIH OAR Leadership at the U.S. Conference on HIV/AIDS. https://t.co/cxNVfDhoyy https://t.co/YTaaR2VQrV | ||
| Details | Retweet | ||
| HIVinfo.NIH.gov HIVinfo_NIH | 06 Jan | |
| 3 things to know about HIV treatment: HIV medicines cant cure HIV, but they help people with HIV live longer, heal https://t.co/6inzO00gzb | ||
| Details | Retweet | ||
You are subscribed as [email protected]. Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the govDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.
This service is provided to you at no charge by HIVinfo.
| This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: HIVinfo 8600 Rockville Pike Bethesda, MD 20894 888-346-3656 |
Laden...
Laden...
